Search Results - "Patil, Suyash M"

Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment by Sawant, Shruti S, Patil, Suyash M, Gupta, Vivek, Kunda, Nitesh K

“…Conventional anti-cancer therapy involves the use of chemical chemotherapeutics and radiation and are often non-specific in action. The development of drug…”
Get full text

An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery by Petkar, Kailash C, Patil, Suyash M, Chavhan, Sandip S, Kaneko, Kan, Sawant, Krutika K, Kunda, Nitesh K, Saleem, Imran Y

“…The development of vaccines is one of the most significant medical accomplishments which has helped to eradicate a large number of diseases. It has undergone…”
Get full text

Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment by Rongala, Druva Sarika, Patil, Suyash M, Kunda, Nitesh K

“…Tuberculosis (TB) is an airborne bacterial infection caused by ( ), resulting in approximately 1.3 million deaths in 2022 worldwide. Oral therapy with anti-TB…”
Get full text

Exosomes as drug delivery systems: A brief overview and progress update by Patil, Suyash M., Sawant, Shruti S., Kunda, Nitesh K.

“…[Display omitted] Exosomes are intracellular membrane-based vesicles with diverse compositions that are involved in biological and pathological processes…”
Get full text

Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture by Patil, Suyash M., Kunda, Nitesh K.

“…Lung cancer is the leading cause of cancer deaths globally with most of the reported cases (> 85%) associated with non-small cell lung cancer (NSCLC). Current…”
Get full text

Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC) by Patil, Suyash M., Sawant, Shruti S., Kunda, Nitesh K.

“…[Display omitted] •Bedaquiline-loaded cubosomes (BQLC) displayed excellent particle size, zeta potential, and aerosolization behavior suitable for NSCLC…”
Get full text

Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro by Vartak, Richa, Patil, Suyash M, Saraswat, Aishwarya, Patki, Manali, Kunda, Nitesh K, Patel, Ketan

“…To formulate an aerosolized nanoliposomal carrier for remdesivir (AL-Rem) against coronavirus disease 2019. AL-Rem was prepared using modified hydration…”
Get full text

Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC) by Patil, Suyash M., Kunda, Nitesh K.

“…Non-small cell lung cancer (NSCLC) is a major cause of global cancer mortalities and accounts for approximately 80–85% of reported lung cancer cases…”
Get full text

A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment by Patil, Suyash M., Diorio, Alec M., Kommarajula, Parasharamulu, Kunda, Nitesh K.

“…[Display omitted] Tuberculosis (TB) is caused by Mycobacterium tuberculosis (M.tb) and is the second leading cause of death from an infectious disease…”
Get full text

Oral inhalation of dacomitinib nanocarriers as a therapeutic strategy for non-small cell lung cancer by Rongala, Druva Sarika, Patil, Suyash M, Kunda, Nitesh K

“…Development of an inhalable nanoformulation of dacomitinib (DMB) encapsulated in poly-(lactic-co-glycolic acid) nanoparticles (NPs) to improve solubility,…”
Get more information

Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment by Patil, Suyash M., Barji, Druva Sarika, Aziz, Sophia, McChesney, David A., Bagde, Shapali, Muttil, Pavan, Kunda, Nitesh K.

“…[Display omitted] Nisin ZP is an antimicrobial peptide (AMP) produced by the bacterium Lactococcus lactis, and we have previously demonstrated anticancer…”
Get full text

Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation by Sawant, Shruti S., Patil, Suyash M., Shukla, Snehal K., Kulkarni, Nishant S., Gupta, Vivek, Kunda, Nitesh K.

“…Osimertinib (OB) is a third-generation irreversible tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR), overexpressed in non-small…”
Get full text

Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment by Patil, Suyash M., Barji, Druva Sarika, Chavan, Tejashri, Patel, Kinjal, Collazo, Andrew J., Prithipaul, Vasudha, Muth, Aaron, Kunda, Nitesh K.

“…Tuberculosis (TB) is a contiguous airborne disease caused by Mycobacterium tuberculosis ( M.tb ), primarily affecting the human lungs. The progression of…”
Get full text